Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1991 1
1992 2
1993 2
1994 2
1997 4
1999 1
2001 1
2005 1
2014 1
2015 5
2016 7
2017 2
2018 1
2019 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up.
Forss A, Clements M, Myrelid P, Strid H, Söderman C, Wagner A, Andersson D, Hjelm F; PROSE SWIBREG study group, Olén O, Ludvigsson JF, Halfvarson J. Forss A, et al. Among authors: soderman c. Scand J Gastroenterol. 2021 Jun;56(6):680-686. doi: 10.1080/00365521.2021.1906946. Epub 2021 Apr 1. Scand J Gastroenterol. 2021. PMID: 33794731 Free article.
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Eriksson C, Rundquist S, Lykiardopoulos V, Udumyan R, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Gunnarsson J, Malmgren C, Delin J, Strid H, Sjöberg M, Öberg D, Bergemalm D, Hjortswang H, Halfvarson J; SWIBREG SVEAH Study Group. Eriksson C, et al. Among authors: soderman c. Therap Adv Gastroenterol. 2021 Jul 3;14:17562848211023386. doi: 10.1177/17562848211023386. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34276808 Free PMC article.
33 results